THE METABOLIC STRESSER 2-DEOXY-D-GLUCOSE (2-DG) ENHANCES LPS-STIMULATED CYTOKINE PRODUCTION IN MICE

被引:14
|
作者
MILLER, ES
KOEBEL, DA
SONNENFELD, G
机构
[1] Univ Louisville, Sch Med, Dept Microbiol and Immunol, Louisville
关键词
D O I
10.1006/brbi.1993.1031
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study was designed to evaluate the influence of metabolic stress on murine cytokine production in vivo. Female Swiss-Webster mice were exposed to a single or multiple injections of the metabolic stressor 2-deoxy-D-glucose (2-DG; 500 mg/kg body wt) once every 48 h and then were injected intravenously with 10 μg of bacterial lipopolysaccharide to stimulate macrophage-derived cytokine production. Plasma samples were harvested 2 h later and were assayed for interleukin (IL)-1, IL-3, and IL-6 activities using a panel of standardized bioassays. It was found that one, two, or three injections of 2-DG enhanced the production of all three cytokines. An attenuation of the enhancing effect was observed following the fourth and fifth injections. These results demonstrate that the metabolic stressor 2-DG can alter immune cell effector functions, including the enhancement of normal patterns of cytokine production in vivo. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 50 条
  • [1] INSULIN VERSUS 2-DEOXY-D-GLUCOSE - OR 2-DG OR NOT 2-DG - UNANSWERED QUESTION
    ISENBERG, JI
    [J]. GASTROENTEROLOGY, 1972, 63 (04) : 701 - &
  • [2] Characterization of the effect of 2-deoxy-D-glucose (2-DG) on the immune system
    Chou, SH
    Kojic, LD
    Messingham, KN
    Cunnick, JE
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 1996, 10 (04) : 399 - 416
  • [3] 2-Deoxy-D-Glucose (2-DG) as a glycolytic inhibitor in the treatment of retinoblastoma
    Decatur, Christina
    Pina, Yolanda
    Houston, Samuel
    Cayalcante, Ludimila
    Shah, Nikesh
    Murray, Timothy
    [J]. CANCER RESEARCH, 2011, 71
  • [4] HYPOTHERMIA FOLLOWING 2-DEOXY-D-GLUCOSE (2-DG) INJECTION INTO SELECTED HYPOTHALAMIC SITES
    SHIRAISH.T
    MAGER, M
    [J]. FEDERATION PROCEEDINGS, 1974, 33 (03) : 408 - 408
  • [5] Targeting inflammation induced carcinogenesis by dietary administration of 2-deoxy-D-glucose (2-DG)
    Pandey, S.
    Singh, S.
    Anang, V.
    Seth, S.
    Bhatt, A. N.
    Manda, K.
    Natarajan, K.
    Dwarakanath, B. S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 54 : S21 - S21
  • [6] 2-Deoxy-D-glucose (2-DG) combination with ketogenic diet induces sedation and hypothermia in mice that becomes lethal
    Zielinski, Rafal
    Castillo, Moises Martinez
    Grybowski, Damian
    Grela, Krzysztof
    Cardenas-Zuniga, Roberto
    Fokt, Izabela
    Skora, Stanislaw
    Ramirez, Gerardo
    Priebe, Waldemar
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [7] Activation of macrophages by the glycolytic inhibitor 2-deoxy-D-glucose (2-DG): Implications for tumor therapy
    Farooque, Abdullah
    Singh, Saurabh
    Verma, Amit
    Afrin, Farhat
    Adhikari, Jawahar
    Dwarakanath, Bilikere
    [J]. CANCER RESEARCH, 2009, 69
  • [8] EFFECTS OF CHLORDIMEFORM (CDM), CHLORDIAZEPOXIDE (CDP), AND 2-DEOXY-D-GLUCOSE (2-DG) ON FEEDING AND GLYCEMIC RESPONSES IN MICE AND RATS
    PFISTER, WR
    YIM, GKW
    [J]. FEDERATION PROCEEDINGS, 1979, 38 (03) : 863 - 863
  • [9] 2-Deoxy-D-Glucose Enhances Anesthetic Effects in Mice
    Wang, Hui
    Xu, Zhipeng
    Wu, Anshi
    Dong, Yuanlin
    Zhang, Yiying
    Yue, Yun
    Xie, Zhongcong
    [J]. ANESTHESIA AND ANALGESIA, 2015, 120 (02): : 312 - 319
  • [10] Optimization of Tumor Radiotherapy Part VI: Modification of Tumor Glucose Metabolism for Increasing the Bioavailability of 2-Deoxy-D-Glucose (2-DG) in a Mutine Tumor ModelPart VI: Modification of Tumor Glucose Metabolism for Increasing the Bioavailability of 2-Deoxy-D-Glucose (2-DG) in a Mutine Tumor Model
    Rakesh Kumar Sharma
    Surender Singh
    Mahavir Degaonkar
    Partha Raghunathan
    Amarnath Maitra
    Viney Jain
    [J]. Strahlentherapie und Onkologie, 2000, 176 (3) : 135 - 143